Changing skin can make a simple daily serum appealing. XOMD presents Intoxicate within a larger skincare system, however, and the evidence cannot be detached from that context. A reader comparing one bottle with a complete routine needs to know which preparation was described in the study and which items the displayed price buys.
The Midlife Skin Edit examined XOMD’s product, study and refund pages on October 14, 2026. No serum was purchased or worn, and no patient outcome was assessed. Our review follows the public record without treating menopause-focused marketing as a requirement to add a product or evidence that every skin concern has the same cause.
- Formula boundary
- No estriol, estradiol or oxytocin declared; not an assay
- Study scope
- Three-product regimen over eight weeks
- Serum price
- $188 observed
- Bundle comparison
- $370 versus $391 sum of displayed singles
- Direct return clock
- Request within 30 days of receipt; conditions apply
The declaration does not list an estrogen ingredient
The checked ingredient list does not declare estriol, estradiol or oxytocin. That observation describes the published label; it is not an independent chemical assay. Technology language on a cosmetic page should not be used to insert a hormone into the formula when the declaration does not name it. [1]
Our estriol questions explain why hormone identity belongs near the start of a comparison. Intoxicate should not be casually grouped with an estriol prescription solely because the products share an intended audience or discuss some of the same visible changes at midlife.
The clinical account concerns the complete routine
XOMD describes an eight-week randomized, double-blind, placebo-controlled study published in the Journal of Cosmetic Dermatology on July 17, 2024. The manufacturer’s account concerns its three-product regimen, rather than an isolated test of the serum purchased on its own. That distinction limits how the results can be assigned. [2]
We have not independently appraised the full paper as a serum-only efficacy result. The claims guide asks which products participants actually used. A study of a routine cannot reveal how much of an observed change came from each component without an appropriate design.
A study presentation still needs the endpoint details
Animated counters that appear as zero in a static capture are not study data. We do not turn them into a conclusion that nobody improved or replace them with guessed percentages. A complete interpretation would require the stated endpoints, methods and population from the underlying study record. [2]
The same caution applies to an audience label such as mature skin. It does not establish that the participants match every reader’s age, symptoms or current treatment. The review therefore avoids a personal prediction, an injectable-equivalence claim or a universal timeline based on a promotional summary alone.
The serum and the regimen have different totals
The captured product offer listed Intoxicate at $188. The cleanser was listed at $48 and moisturizer at $155, while the three-product bundle was $370. The individual amounts sum to $391, a $21 difference from the bundle. That arithmetic compares the displayed offers, not observed treatment value. [1]
A reader considering the study regimen should not assume the serum price buys all three products. Our budget guide also leaves delivery charges and personal usage duration separate. We did not complete checkout, verify inventory allocation or measure how long any bottle would last.
The return route depends on the actual purchase
The direct refund page describes a thirty-day request period from receipt, authorization and possible fees. Subscription arrangements and purchases through TikTok have separate conditions. Those distinctions matter before a buyer assumes a return summary applies to every order placed under the same brand name. [3]
We did not initiate a subscription, contact support or test reimbursement. Save the seller and selected purchase mode with the order details. A stated return window provides useful information, but it should not become an unconditional promise of a free trial or a measured claim about customer-service speed.
Keep comfort questions separate from research headlines
No application test means this publication cannot report texture, scent, pilling or comfort under another moisturizer. AAD’s general guidance on testing skincare provides context for considering a new product, without establishing compatibility with an existing prescription or endorsing this serum for an individual. [4]
The comfort-first article encourages a specific question about what a proposed addition is meant to do. A person seeking help with dryness may have a different objective from someone comparing cosmetic firmness claims; a study headline does not make those objectives interchangeable.
One bottle deserves a conclusion about one bottle
Intoxicate has an identifiable cosmetic declaration and a dated offer, while the cited clinical account belongs to a broader routine. That is enough to describe the purchase clearly, but it leaves a serum-only outcome unresolved. A future comparison should retain the exact regimen and its source rather than compressing everything into a single percentage.
CoreAge Rx’s featured advertisement is labeled separately from this review. It supplies no evidence that XOMD or another listed product performs better. The Midlife Skin Edit offers a documented comparison without an invented performance score, personal testimonial or claim that hormonal and cosmetic routes are interchangeable.
Sources & further reading
Provider pages establish what a brand markets. Clinical and regulatory sources establish the limits of the evidence. Each source has its own last-checked date below.
- XOMD Intoxicate Serum - Ignite the Confidence that AttractsOfficial product or purchase record; claims and transaction performance not independently tested · Checked October 14, 2026
- Clinical Study Results – XOMDOfficial product or purchase record; claims and transaction performance not independently tested · Checked October 14, 2026
- Refund policy – XOMDOfficial product or purchase record; claims and transaction performance not independently tested · Checked October 14, 2026
- AAD: testing skincare productsGeneral cosmetic guidance rechecked November 14, 2026; this does not replace prescription instructions. · Checked November 14, 2026